Subcutaneous administration of anti-CD38 antibodies
US-12371506-B2 · Jul 29, 2025 · US
Evans Robert is listed as an inventor on 16 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Evans Robert |
| Total patents | 16 |
| First publication | Jan 15, 2015 |
| Latest publication | Jul 29, 2025 |
Publications ranked by popularity score, then publication date.
US-12371506-B2 · Jul 29, 2025 · US
US-2025059596-A1 · Feb 20, 2025 · US
US-2024082380-A1 · Mar 14, 2024 · US
US-2022204631-A1 · Jun 30, 2022 · US
US-11214621-B2 · Jan 4, 2022 · US
US-2021388103-A1 · Dec 16, 2021 · US
US-2019321457-A1 · Oct 24, 2019 · US
US-10314904-B2 · Jun 11, 2019 · US
US-2019040146-A1 · Feb 7, 2019 · US
US-2019040147-A1 · Feb 7, 2019 · US
Latest publications not already listed above.
US-10183968-B2 · Jan 22, 2019 · US
US-10066017-B2 · Sep 4, 2018 · US
US-10059771-B2 · Aug 28, 2018 · US
US-2017239342-A1 · Aug 24, 2017 · US
US-2016185866-A1 · Jun 30, 2016 · US
US-2015017182-A1 · Jan 15, 2015 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Regeneron Pharma | 13 |
| Sanofi Biotechnology | 7 |
| Takeda Pharmaceuticals Co | 2 |
| Univ California | 1 |
| Merck Sharp & Dohme | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K2039/505 | 14 |
| C07K2317/21 | 12 |
| A61K39/3955 | 12 |
| C07K16/2866 | 12 |
| A61K2039/545 | 11 |